MAK683 free base · Synonyms: MAK-683 · MAK 683
MAK683 is an embryonic ectoderm development (EED) inhibitor extracted from patent US20160176882 A1, compound example 2; has IC50s of 59, 89, 26 nM…
For research use only. Not for human or veterinary use.
Target
Histone Methyltransferase
Research area
Cancer
Purity >98%
Stock Inquire
MAK683 structure
CAS No.: 1951408-58-4
Pack sizes & pricing
Description
MAK683 is an embryonic ectoderm development (EED) inhibitor extracted from patent US20160176882 A1, compound example 2; has IC50s of 59, 89, 26 nM in EED Alphascreen binding, LC-MS and ELISA assay.
Biological activity
In Vitro MAK683 has antiproliferative activities in B cell lymphoma cell KARPAS422 after 14 days of treatment with an IC50 of 30 nM[1].
Identifiers
- SMILES
-
CC1=C(C=CC=N1)C1=CN=C(NCC2=C(F)C=CC3=C2CCO3)N2C=NN=C12 - InChIKey
-
XLIBABIFOBYHSV-UHFFFAOYSA-N
Specifications
- MW (average)
- 376.3870
- Formula
- C20H17FN6O
- CAS No.
- 1951408-58-4
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO >50mg/mL; Insoluble in water
Documents
References
[1]. Chan, Ho Man, et al. TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF. US20160176882 A1.
[2]. Huang D, et al. Binding Modes of Small-Molecule Inhibitors to the EED Pocket of PRC2. Chemphyschem. 2020 Feb 4;21(3):263-271.
Same target
Search Histone MethyltransferaseSame research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%